http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09296174-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f5ef33cec3537b306a172695f828500
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-24
filingDate 1996-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e8507c648743f43e8b030d4ee6e5ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f631fe9c8ad716832b37750b720188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6dda6d8b9734683378b88a49111456f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cd16df368c7c37bd504e92e5ccad036
publicationDate 1997-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H09296174-A
titleOfInvention Liquid crystal device using a novel optically active compound having an azo bond
abstract (57) [Abstract] (Correction) [Problem] New liquid crystal device using a novel optically active compound having an azo bond (Compound 1) and Compound 1 which undergoes phase transition from antiferroelectric phase to ferroelectric phase upon irradiation with ultraviolet light Providing a new liquid crystal element using. SOLUTION: General formula 1 (R 1 is an alkyl group of C4~16, R 2 is an alkyl group of C2-12, Cf is CH 3, C 2 H 5, CF 3, C 2 F 5, C 3 F 7 , CHF 2 or CH 2 F, X is O, COO, OC O, CO or a single bond, and ring A is 1,4-phenylene group which may be partially substituted with hydrogen by halogen, 1,3-phenylene group, pyrimidine-2,5-diyl, pyridine-2, 5-diyl or trans-1,4-cyclohexylene group, ring B and ring C are 1,4-phenylene group in which hydrogen may be partially substituted with halogen, m and n are 0 or 1, ring D is n When is 0, it is a single bond. When n is 1, it is halogen and hydrogen is 1. Partially substituted 1,4-phenylene group or biphenyl-4-4'-diyl group, * represents an optically active carbon. 3.) A liquid crystal device using a liquid crystal containing the optically active compound of.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7298429-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02084387-A1
priorityDate 1996-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426687130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16723172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426262184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53628834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418598895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24978618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426262178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234366085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24980096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152005373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135563810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424572041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433241720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453058690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408038982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424382124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13089985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431176386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89655759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426625568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14549216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7010345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390726

Total number of triples: 75.